{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T08:48:07Z","timestamp":1784882887726,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T00:00:00Z","timestamp":1689724800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1007\/s00277-023-05364-6","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T20:27:01Z","timestamp":1689798421000},"page":"3399-3411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Rasburicase-induced hemolytic anemia and methemoglobinemia: a systematic review of current reports"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3422-5163","authenticated-orcid":false,"given":"M Bakri","family":"Hammami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charan Thej Reddy","family":"Vegivinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline Delbourgo","family":"Patton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu","family":"Vikash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,19]]},"reference":[{"key":"5364_CR1","unstructured":"Elitek (rasburicase) Package Insert. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2002\/rasbsan071202LB.pdf. Accessed 22 Sept 2022"},{"issue":"6","key":"5364_CR2","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1056\/NEJMc1106641","volume":"365","author":"JM Elinoff","year":"2011","unstructured":"Elinoff JM, Salit RB, Ackerman HC (2011) The tumor lysis syndrome. N Engl J Med 365(6):571\u2013572. https:\/\/doi.org\/10.1056\/NEJMc1106641","journal-title":"N Engl J Med"},{"issue":"1","key":"5364_CR3","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11096-011-9484-3","volume":"33","author":"T Bauters","year":"2011","unstructured":"Bauters T, Mondelaers V, Robays H, De Wilde H, Benoit Y, De Moerloose B (2011) Methemoglobinemia and hemolytic anemia after rasburicase administration in a child with leukemia. Int J Clin Pharm 33(1):58\u201360. https:\/\/doi.org\/10.1007\/s11096-011-9484-3","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"5364_CR4","doi-asserted-by":"publisher","first-page":"386","DOI":"10.5858\/arpa.2017-0278-RS","volume":"143","author":"SM Williams","year":"2019","unstructured":"Williams SM, Killeen AA (2019) Tumor lysis syndrome. Arch Pathol Lab Med 143(3):386\u2013393. https:\/\/doi.org\/10.5858\/arpa.2017-0278-RS","journal-title":"Arch Pathol Lab Med"},{"issue":"2","key":"5364_CR5","doi-asserted-by":"publisher","first-page":"151136","DOI":"10.1016\/j.soncn.2021.151136","volume":"37","author":"JS Webster","year":"2021","unstructured":"Webster JS, Kaplow R (2021) Tumor lysis syndrome: implications for oncology nursing practice. Semin Oncol Nurs 37(2):151136. https:\/\/doi.org\/10.1016\/j.soncn.2021.151136","journal-title":"Semin Oncol Nurs"},{"issue":"5","key":"5364_CR6","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/(SICI)1097-0142(19990301)85:5<1055::AID-CNCR7>3.0.CO;2-3","volume":"85","author":"MP Castro","year":"1999","unstructured":"Castro MP, VanAuken J, Spencer-Cisek P, Legha S, Sponzo RW (1999) Acute tumor lysis syndrome associated with concurrent biochemotherapy of metastatic melanoma: a case report and review of the literature. Cancer 85(5):1055\u20131059 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10091788","journal-title":"Cancer"},{"issue":"10","key":"5364_CR7","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1177\/1060028013501996","volume":"47","author":"MH Bucklin","year":"2013","unstructured":"Bucklin MH, Groth CM (2013) Mortality following rasburicase-induced methemoglobinemia. Ann Pharmacother 47(10):1353\u20131358. https:\/\/doi.org\/10.1177\/1060028013501996","journal-title":"Ann Pharmacother"},{"issue":"16","key":"5364_CR8","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.1200\/JCO.2007.15.0177","volume":"26","author":"B Coiffier","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS (2008) Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol 26(16):2767\u20132778. https:\/\/doi.org\/10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"},{"issue":"2","key":"5364_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/clpt.2014.97","volume":"96","author":"MV Relling","year":"2014","unstructured":"Relling MV et al (2014) Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for rasburicase therapy in the context of G6PD deficiency genotype. Clin Pharmacol Ther 96(2):169\u2013174. https:\/\/doi.org\/10.1038\/clpt.2014.97","journal-title":"Clin Pharmacol Ther"},{"key":"5364_CR10","unstructured":"Sanofi-Aventis DailyMed - elitek- rasburicase kit. U.S. National Library of Medicine. https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=0ae10bc4-6b65-402f-9db5-2d7753054922&audience=consumer. Accessed 22 Sept 2023"},{"issue":"1","key":"5364_CR11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/sj.leu.2403566","volume":"19","author":"S Jeha","year":"2005","unstructured":"Jeha S et al (2005) Efficacy and safety of rasburicase, a recombinant urate oxidase (Elitek\u2122), in the management of malignancy-associated hyperuricemia in pediatric and adult patients: Final results of a multicenter compassionate use trial. Leukemia 19(1):34\u201338. https:\/\/doi.org\/10.1038\/sj.leu.2403566","journal-title":"Leukemia"},{"issue":"4","key":"5364_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1177\/1078155211429385","volume":"18","author":"JS Ng","year":"2012","unstructured":"Ng JS, Edwards EM, Egelund TA (2012) Methemoglobinemia induced by rasburicase in a pediatric patient: A case report and literature review. J Oncol Pharm Pract 18(4):425\u2013431. https:\/\/doi.org\/10.1177\/1078155211429385","journal-title":"J Oncol Pharm Pract"},{"key":"5364_CR13","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"issue":"2","key":"5364_CR14","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1136\/bmjebm-2017-110853","volume":"23","author":"MH Murad","year":"2018","unstructured":"Murad MH, Sultan S, Haffar S, Bazerbachi F (2018) Methodological quality and synthesis of case series and case reports. BMJ Evid Based Med 23(2):60\u201363. https:\/\/doi.org\/10.1136\/bmjebm-2017-110853","journal-title":"BMJ Evid Based Med"},{"issue":"4","key":"5364_CR15","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/pbc.21582","volume":"51","author":"P Bhat","year":"2008","unstructured":"Bhat P, Sisler I, Collier Iii AB (2008) Exchange transfusion as treatment for rasburicase induced methemoglobinemia in a glucose-6-phosphate dehydrogenase deficient patient. Pediatr Blood Cancer 51(4):568. https:\/\/doi.org\/10.1002\/pbc.21582","journal-title":"Pediatr Blood Cancer"},{"key":"5364_CR16","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1002\/pbc.25032","volume":"61","author":"J Bistolarides","year":"2014","unstructured":"Bistolarides J, Nicolaou E, Braunreiter C (2014) Rasburicase-induced methemoglobinemia and hemolysis in a female patient. Pediatr Blood Cancer 61:S69. https:\/\/doi.org\/10.1002\/pbc.25032","journal-title":"Pediatr Blood Cancer"},{"key":"5364_CR17","doi-asserted-by":"crossref","first-page":"13A","DOI":"10.1111\/j.1537-2995.2008.01941.x","volume":"49","author":"MM Bombery","year":"2009","unstructured":"Bombery MM, Armelagos H, Cooling L (2009) A severe case of rasburicase-induced methemoglobinemia treated by erythrocytopheresis. Transfusion 49:13A https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L70006143&from=export","journal-title":"Transfusion"},{"key":"5364_CR18","doi-asserted-by":"publisher","unstructured":"Bontant T, Le Garrec S, Avran D, Dauger S (2014) Methaemoglobinaemia in a G6PD-deficient child treated with rasburicase. BMJ Case Rep 2014. https:\/\/doi.org\/10.1136\/bcr-2014-204706","DOI":"10.1136\/bcr-2014-204706"},{"issue":"1","key":"5364_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/pbc.21193","volume":"50","author":"SC Borinstein","year":"2008","unstructured":"Borinstein SC, Hawkins DS, Xu M (2008) Methemoglobinemia and hemolytic anemia caused by rasburicase administration in a newly diagnosed child with Burkitt lymphoma\/leukemia [4]. Pediatr Blood Cancer 50(1):189. https:\/\/doi.org\/10.1002\/pbc.21193","journal-title":"Pediatr Blood Cancer"},{"issue":"11","key":"5364_CR20","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1345\/aph.1G272","volume":"39","author":"LA Browning","year":"2005","unstructured":"Browning LA, Kruse JA (2005) Hemolysis and methemoglobinemia secondary to rasburicase administration. Ann Pharmacother 39(11):1932\u20131935. https:\/\/doi.org\/10.1345\/aph.1G272","journal-title":"Ann Pharmacother"},{"issue":"10","key":"5364_CR21","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/ccr3.3011","volume":"8","author":"P Cabantous","year":"2020","unstructured":"Cabantous P, Daliphard S, Bob\u00e9e V (2020) Erythrocyte hemighosts in a patient with tumor lysis syndrome: one train may hide another. Clin Case Rep 8(10):2069\u20132070. https:\/\/doi.org\/10.1002\/ccr3.3011","journal-title":"Clin Case Rep"},{"issue":"4","key":"5364_CR22","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1159\/000351048","volume":"130","author":"CY Cheah","year":"2013","unstructured":"Cheah CY, Lew TE, Seymour JF, Burbury K (2013) Rasburicase causing severe oxidative hemolysis and methemoglobinemia in a patient with previously unrecognized glucose-6-phosphate dehydrogenase deficiency. Acta Haematol 130(4):254\u2013259. https:\/\/doi.org\/10.1159\/000351048","journal-title":"Acta Haematol"},{"issue":"6","key":"5364_CR23","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/jca.21540","volume":"32","author":"L Cooling","year":"2017","unstructured":"Cooling L (2017) Brisk clinical response to erythrocytapheresis in a G6PD-deficient patient with rasburicase-induced methemoglobinemia. J Clin Apher 32(6):599\u2013600. https:\/\/doi.org\/10.1002\/jca.21540","journal-title":"J Clin Apher"},{"issue":"1","key":"5364_CR24","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/jca.21314","volume":"29","author":"R Dasararaju","year":"2014","unstructured":"Dasararaju R, Tracht J, Adamski J (2014) Multimodal apheresis therapy for lifethreatening rasburicase-induced methemoglobinemia. J Clin Apher 29(1):22\u201323. https:\/\/doi.org\/10.1002\/jca.21314","journal-title":"J Clin Apher"},{"key":"5364_CR25","doi-asserted-by":"publisher","first-page":"A261","DOI":"10.1097\/01.ccm.0000390903.16849.8c","volume":"38","author":"A Fayazi","year":"2010","unstructured":"Fayazi A, Sreedhar S, Marinello M, Chowdhury S (2010) Hyperleukocytosis and rasburicase-induced methemoglobinemia: therapeutic challenges. Crit Care Med 38:A261. https:\/\/doi.org\/10.1097\/01.ccm.0000390903.16849.8c","journal-title":"Crit Care Med"},{"issue":"2","key":"5364_CR26","doi-asserted-by":"publisher","first-page":"S691","DOI":"10.1007\/11606.1525-1497","volume":"34","author":"C Feng","year":"2019","unstructured":"Feng C, Katz A, Sutherland A, Wiese J (2019) Why it is essentialto think two moves down the chess game. J Gen Intern Med 34(2):S691\u2013S692. https:\/\/doi.org\/10.1007\/11606.1525-1497","journal-title":"J Gen Intern Med"},{"issue":"6","key":"5364_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2018-04-842724","volume":"132","author":"D Ferguson","year":"2018","unstructured":"Ferguson D, Kovach AE (2018) Rasburicase-induced hemolytic anemia in previously undiagnosed G6PD deficiency. Blood 132(6):673. https:\/\/doi.org\/10.1182\/blood-2018-04-842724","journal-title":"Blood"},{"issue":"5","key":"5364_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1017\/cem.2020.33","volume":"22","author":"N Friedman","year":"2020","unstructured":"Friedman N, Scolnik D, McMurray L, Bryan J (2020) Acquired methemoglobinemia presenting to the pediatric emergency department: a clinical challenge. Can J Emergency Med 22(5):673\u2013677. https:\/\/doi.org\/10.1017\/cem.2020.33","journal-title":"Can J Emergency Med"},{"issue":"9","key":"5364_CR29","doi-asserted-by":"publisher","first-page":"4163","DOI":"10.1111\/bcp.15353","volume":"88","author":"M Ganapathi","year":"2022","unstructured":"Ganapathi M, Campbell P, Ofori K, Aggarwal V, Francis RO, Kratz A (2022) Impact of pre-emptive rapid testing for glucose-6-phosphate dehydrogenase deficiency prior to rasburicase administration at a tertiary care centre: a retrospective study. Br J Clin Pharmacol 88(9):4163\u20134170. https:\/\/doi.org\/10.1111\/bcp.15353","journal-title":"Br J Clin Pharmacol"},{"key":"5364_CR30","doi-asserted-by":"publisher","first-page":"S380","DOI":"10.1007\/s11606-022-07653-8","volume":"37","author":"S Ingham","year":"2022","unstructured":"Ingham S, Akhtar Z, Wall G, Jawa Z (2022) Intravenous vitamin C for the treatment of methemoglobinemia in the setting of G6PD deficiency. J Gen Intern Med 37:S380. https:\/\/doi.org\/10.1007\/s11606-022-07653-8","journal-title":"J Gen Intern Med"},{"key":"5364_CR31","doi-asserted-by":"publisher","first-page":"196A","DOI":"10.1111\/j.1537-2995.2012.03833-1.x","volume":"52","author":"SH Kang","year":"2012","unstructured":"Kang SH, Xie Q (2012) Exchange transfusion for rasburicase induced methemoglobinemia in a G6PD deficient patient. Transfusion 52:196A. https:\/\/doi.org\/10.1111\/j.1537-2995.2012.03833-1.x","journal-title":"Transfusion"},{"issue":"1","key":"5364_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2174\/1574886312666170111151246","volume":"12","author":"M Khan","year":"2017","unstructured":"Khan M, Paul S, Farooq S, Oo TH, Ramshesh P, Jain N (2017) Rasburicase-Induced methemoglobinemia in a patient with glucose-6- phosphate dehydrogenase deficiency. Curr Drug Saf 12(1):13\u201318. https:\/\/doi.org\/10.2174\/1574886312666170111151246","journal-title":"Curr Drug Saf"},{"issue":"2","key":"5364_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1136\/jim-2018-000974.358","volume":"67","author":"M Leibman","year":"2019","unstructured":"Leibman M, Natarajan R, Arsenegas S (2019) Rasburicase induced methemoglobinemia in Lesch-Nyhan disease and previously unrecognized glucose-6-phosphate dehydrogenase deficiency. J Invest Med 67(2):492. https:\/\/doi.org\/10.1136\/jim-2018-000974.358","journal-title":"J Invest Med"},{"key":"5364_CR34","doi-asserted-by":"publisher","unstructured":"Madanat L, Schoenherr D, Wey E, Gupta R (2021) Rasburicase-induced haemolysis and methemoglobinemia: an ongoing issue. BMJ Case Rep 14(3). https:\/\/doi.org\/10.1136\/bcr-2020-240967","DOI":"10.1136\/bcr-2020-240967"},{"issue":"1","key":"5364_CR35","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/jca.21462","volume":"32","author":"KW Montgomery","year":"2017","unstructured":"Montgomery KW, Booth GS (2017) A perfect storm: tumor lysis syndrome with rasburicase-induced methemoglobinemia in a G6PD deficient adult. J Clin Apher 32(1):62\u201363. https:\/\/doi.org\/10.1002\/jca.21462","journal-title":"J Clin Apher"},{"issue":"5","key":"5364_CR36","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1111\/bjh.13513","volume":"170","author":"A Oluwasanjo","year":"2015","unstructured":"Oluwasanjo A, Alese O, Swierczynski S, Forman D (2015) Rasburicase-induced methaemoglobinaemia and G6PD deficiency in an unusual suspect. Br J Haematol 170(5):595. https:\/\/doi.org\/10.1111\/bjh.13513","journal-title":"Br J Haematol"},{"issue":"6","key":"5364_CR37","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1007\/s00467-013-2568-7","volume":"29","author":"J Pansy","year":"2014","unstructured":"Pansy J, Mache CJ, Zobel G, Grangl G, Ring E, Hoffmann KM (2014) Cyanosis in a male Nigerian infant with acute kidney injury: answers. Pediatr Nephrol 29(6):1011\u20131013. https:\/\/doi.org\/10.1007\/s00467-013-2568-7","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"5364_CR38","doi-asserted-by":"publisher","first-page":"E886","DOI":"10.1097\/MPH.0000000000001979","volume":"43","author":"I Pirrone","year":"2021","unstructured":"Pirrone I et al (2021) Rasburicase-induced methemoglobinemia: a case report and literature review. J Pediatr Hematol Oncol 43(6):E886\u2013E890. https:\/\/doi.org\/10.1097\/MPH.0000000000001979","journal-title":"J Pediatr Hematol Oncol"},{"key":"5364_CR39","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.rmcr.2018.12.011","volume":"26","author":"Y Raru","year":"2019","unstructured":"Raru Y, Abouzid M, Parsons J, Zeid F (2019) Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ARDS. Respir Med Case Rep 26:142\u2013145. https:\/\/doi.org\/10.1016\/j.rmcr.2018.12.011","journal-title":"Respir Med Case Rep"},{"key":"5364_CR40","doi-asserted-by":"crossref","unstructured":"Raru Y, Abouzid M, Parsons J, Zeid FM (2019) Rasburicase induced severe hemolysis and methemoglobinemia in a Caucasian patient complicated by acute renal failure and ards. Am J Respir Crit Care Med 199(9). https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L630354816&from=export. Accessed 22 Sept 2023","DOI":"10.1164\/ajrccm-conference.2019.199.1_MeetingAbstracts.A6548"},{"issue":"1","key":"5364_CR41","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/ejh.12350","volume":"94","author":"DA Roberts","year":"2015","unstructured":"Roberts DA, Freed JA (2015) Rasburicase-induced methemoglobinemia in two African-American female patients: an under-recognized and continued problem. Eur J Haematol 94(1):83\u201385. https:\/\/doi.org\/10.1111\/ejh.12350","journal-title":"Eur J Haematol"},{"issue":"4","key":"5364_CR42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ccr3.495","volume":"4","author":"GB Sherwood","year":"2016","unstructured":"Sherwood GB, Paschal RD, Adamski J (2016) Rasburicase-induced methemoglobinemia: case report, literature review, and proposed treatment algorithm. Clinical Case Reports 4(4):315\u2013319. https:\/\/doi.org\/10.1002\/ccr3.495","journal-title":"Clinical Case Reports"},{"issue":"2","key":"5364_CR43","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1002\/ajh.23182","volume":"88","author":"MB Sonbol","year":"2013","unstructured":"Sonbol MB, Yadav H, Vaidya R, Rana V, Witzig TE (2013) Methemoglobinemia and hemolysis in a patient with G6PD deficiency treated with rasburicase. Am J Hematol 88(2):152\u2013154. https:\/\/doi.org\/10.1002\/ajh.23182","journal-title":"Am J Hematol"},{"issue":"8","key":"5364_CR44","doi-asserted-by":"publisher","first-page":"e3084","DOI":"10.7759\/cureus.3084","volume":"10","author":"M Younis","year":"2018","unstructured":"Younis M, Derbas L, Eikermann SM, Hamarshi MS (2018) Not the typical pneumonia: an unusual case of rasburicase-induced methomoglobinemia. Cureus 10(8):e3084. https:\/\/doi.org\/10.7759\/cureus.3084","journal-title":"Cureus"},{"issue":"8","key":"5364_CR45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1093\/omcr\/omu053","volume":"2014","author":"B Zhang","year":"2014","unstructured":"Zhang B, Lee AI, Podoltsev N (2014) Tumor lysis syndrome and acute anemia in an African-American man with chronic lymphocytic leukemia. Oxf Med Case Reports 2014(8):138\u2013140. https:\/\/doi.org\/10.1093\/omcr\/omu053","journal-title":"Oxf Med Case Reports"},{"key":"5364_CR46","doi-asserted-by":"publisher","unstructured":"Zulqarnain S, Bradley T, Demitis S (2012) Tumor lysis syndrome in small cell cancer of prostate. Chest 142(4). https:\/\/doi.org\/10.1378\/chest.1388951","DOI":"10.1378\/chest.1388951"},{"key":"5364_CR47","doi-asserted-by":"publisher","unstructured":"M. Akande, A. N. Audino, and J. D. Tobias, Rasburicase-induced hemolytic anemia in an adolescent with unknown glucose-6-phosphate dehydrogenase deficiency, J Pediatr Pharmacol Ther, vol. 22, no. 6, pp. 471-475, Nov-Dec 2017.\u00a0https:\/\/doi.org\/10.5863\/1551-6776-22.6.471.","DOI":"10.5863\/1551-6776-22.6.471"},{"issue":"4","key":"5364_CR48","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1213\/xaa.0000000000000855","volume":"12","author":"KF Bachmann","year":"2019","unstructured":"Bachmann KF et al (2019) Rare case of transcutaneous oxygen desaturation in a cancer patient: a case report and diagnostic approach for a recurrent problem. A A Pract 12(4):96\u201398. https:\/\/doi.org\/10.1213\/xaa.0000000000000855","journal-title":"A A Pract"},{"key":"5364_CR49","unstructured":"Makkar P, Pillai MV, Mehta V (2018) Rasburicase induced methemoglobinemia in a patient with g6pd deficiency- a review of pathophysiology and treatment considerations. Am J Respir Crit Care Med 197. https:\/\/www.embase.com\/search\/results?subaction=viewrecord&id=L622968322&from=export. Accessed 22 Sept 2023"},{"issue":"4","key":"5364_CR50","doi-asserted-by":"publisher","first-page":"A867","DOI":"10.1016\/j.chest.2021.07.813","volume":"160","author":"E Becker","year":"2021","unstructured":"Becker E, Sabharwal S, Congrete S, Soriano J (2021) Rasburicase-induced methemoglobinemia: treating non-critical levels with methylene blue in anemia. Chest 160(4):A867. https:\/\/doi.org\/10.1016\/j.chest.2021.07.813","journal-title":"Chest"},{"issue":"9","key":"5364_CR51","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.2146\/ajhp150591","volume":"73","author":"DJ Reeves","year":"2016","unstructured":"Reeves DJ, Saum LM, Birhiray R (2016) I.V. ascorbic acid for treatment of apparent rasburicase-induced methemoglobinemia in a patient with acute kidney injury and assumed glucose-6-phosphate dehydrogenase deficiency. Am J Health Syst Pharm 73(9):e238\u2013e242. https:\/\/doi.org\/10.2146\/ajhp150591","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"5364_CR52","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2165\/11536520-000000000-00000","volume":"33","author":"I Youngster","year":"2010","unstructured":"Youngster I et al (2010) Medications and glucose-6-phosphate dehydrogenase deficiency an evidence-based review. Drug Saf 33(9):713\u2013726. https:\/\/doi.org\/10.2165\/11536520-000000000-00000","journal-title":"Drug Saf"},{"key":"5364_CR53","volume-title":"Methemoglobinemia","author":"JT Ludlow","year":"2022","unstructured":"Ludlow JT, Wilkerson RG, Nappe TM (2022) Methemoglobinemia. StatPearls, Treasure Island (FL)"},{"issue":"2","key":"5364_CR54","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1046\/j.1365-3156.2000.00529.x","volume":"5","author":"J May","year":"2000","unstructured":"May J et al (2000) Red cell glucose-6-phosphate dehydrogenase status and pyruvate kinase activity in a Nigerian population. Trop Med Int Health 5(2):119\u2013123. https:\/\/doi.org\/10.1046\/j.1365-3156.2000.00529.x","journal-title":"Trop Med Int Health"},{"issue":"3","key":"5364_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.bcmd.2008.12.005","volume":"42","author":"ET Nkhoma","year":"2009","unstructured":"Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42(3):267\u2013278. https:\/\/doi.org\/10.1016\/j.bcmd.2008.12.005","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"5364_CR56","first-page":"14","volume":"26","author":"J Lee","year":"2019","unstructured":"Lee J, Poitras BT (2019) Prevalence of glucose-6-phosphate dehydrogenase deficiency, U.S. Armed Forces, May 2004-September 2018. MSMR 26(12):14\u201317 https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31860324","journal-title":"MSMR"},{"issue":"10","key":"5364_CR57","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1093\/gerona\/61.10.1086","volume":"61","author":"WY Au","year":"2006","unstructured":"Au WY et al (2006) Glucose-6-phosphate dehydrogenase deficiency in female octogenarians, nanogenarians, and centenarians. J Gerontol A Biol Sci Med Sci 61(10):1086\u20131089. https:\/\/doi.org\/10.1093\/gerona\/61.10.1086","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"5364_CR58","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/ajmg.a.30213","volume":"129A","author":"WY Au","year":"2004","unstructured":"Au WY, Ma ES, Lam VM, Chan JL, Pang A, Kwong YL (2004) Glucose 6-phosphate dehydrogenase (G6PD) deficiency in elderly Chinese women heterozygous for G6PD variants. Am J Med Genet A 129A(2):208\u2013211. https:\/\/doi.org\/10.1002\/ajmg.a.30213","journal-title":"Am J Med Genet A"},{"issue":"5","key":"5364_CR59","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/s0196-0644(99)70167-8","volume":"34","author":"RO Wright","year":"1999","unstructured":"Wright RO, Lewander WJ, Woolf AD (1999) Methemoglobinemia: etiology, pharmacology, and clinical management. Ann Emerg Med 34(5):646\u2013656. https:\/\/doi.org\/10.1016\/s0196-0644(99)70167-8","journal-title":"Ann Emerg Med"},{"issue":"4","key":"5364_CR60","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1097\/MJT.0000000000000028","volume":"21","author":"PB Rino","year":"2014","unstructured":"Rino PB, Scolnik D, Fustinana A, Mitelpunkt A, Glatstein M (2014) Ascorbic acid for the treatment of methemoglobinemia: the experience of a large tertiary care pediatric hospital. Am J Ther 21(4):240\u2013243. https:\/\/doi.org\/10.1097\/MJT.0000000000000028","journal-title":"Am J Ther"},{"issue":"4","key":"5364_CR61","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/pds.3370","volume":"22","author":"O Muller","year":"2013","unstructured":"Muller O et al (2013) Haemolysis risk in methylene blue treatment of G6PD-sufficient and G6PD-deficient West-African children with uncomplicated falciparum malaria: a synopsis of four RCTs. Pharmacoepidemiol Drug Saf 22(4):376\u2013385. https:\/\/doi.org\/10.1002\/pds.3370","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"5364_CR62","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ienj.2008.12.005","volume":"17","author":"M Khemiri","year":"2009","unstructured":"Khemiri M, Labassi A Jr, Tlili Y Jr, Barsaoui S (2009) Severe toxic methemoglobinemia mimicking septic shock in an infant. Int Emerg Nurs 17(3):181\u2013183. https:\/\/doi.org\/10.1016\/j.ienj.2008.12.005","journal-title":"Int Emerg Nurs"},{"issue":"5","key":"5364_CR63","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jemermed.2017.04.036","volume":"53","author":"Y Cho","year":"2017","unstructured":"Cho Y, Park SW, Han SK, Kim HB, Yeom SR (2017) A case of methemoglobinemia successfully treated with hyperbaric oxygenation monotherapy. J Emerg Med 53(5):685\u2013687. https:\/\/doi.org\/10.1016\/j.jemermed.2017.04.036","journal-title":"J Emerg Med"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05364-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05364-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,28]],"date-time":"2024-08-28T09:08:49Z","timestamp":1724836129000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05364-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,19]]},"references-count":63,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["5364"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05364-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,19]]},"assertion":[{"value":"27 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Albert Einstein College of Medicine Institutional Review Board (IRB) determined that the study did not require IRB approval. A written consent was obtained from the patient that was reported from our institution before initiating the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"MBH, RT, CV, AQ, CDQ, and SV: no disclosures. AK: Dr. AK has stock investment in ABBV, ACADia Pharma, ADMA, Biologics, AGNEUS, AIKIDO, AMGEN, AVEO Pharma, Astrazeneca, Biotelemetry Inc, Bristol Meyer, Bio-Path Holdings, BeyondSpring Inc., Cara Therapeutics, ChemBio Diagnostics, Contrafect Corp, Cardiff Oncology, CRISPR Therapeutics, CVS Health, Precision Biosciences, EDITAS Medicine Inc., Five Prime Therapeutics, Globus Medicine Inc., IDEXX Laboratories, Iovance Biosciences, Johnson and Johnson, ELiLilly, Northwest Bio, PFIZER, POSEIDA Therapeutics, PTC Therapeutics, Spectrum Pharmaceuticals Inc., Viking Therapeutics, and Vertex Pharmaceuticals.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}